EMA updates Timelines of eAFs for Variations for Medicinal Products for Human Use
Recommendation

9 June 2026
In future, submissions of variation notifications for medicinal products for human use are to be made exclusively via the electronic application forms (eAFs). The timelines for the full implementation of these systems have now been updated again and are listed on the EMA website in the PLM Portal (Product Lifecycle Management Portal).
Under the heading "What's New in PLM?" the newly defined timelines are shown and illustrated in the two-page document made available there. The mandatory use of electronic application forms is set for the end of the third quarter or the beginning of the fourth quarter of 2024 after a six-month transition period.
Please see the EMA website for the updated timelines and further information on the implementation of the electronic submission of variation notifications.
Related GMP News
27.05.2026What should you know about EU and US Drug Approval? Part 2
20.05.2026What should you know about EU and US drug approval? Part 1
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"
04.03.2026CMDh: Update of Q&As for Generic Drug Submissions
18.02.2026HMA/CMDh: Update to the Best Practice Guides on Variations


